• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.清扫29枚淋巴结达最佳状态的淋巴结切除术与晚期胃癌患者生存率提高相关:一项纳入25000例患者的国际数据库研究
J Am Coll Surg. 2017 Apr;224(4):546-555. doi: 10.1016/j.jamcollsurg.2016.12.015. Epub 2016 Dec 23.
2
Survival Analysis with Extended Lymphadenectomy for Gastric Cancer: Removing Stage Migration from the Equation.胃癌扩大淋巴结清扫术的生存分析:消除分期迁移的影响
Am Surg. 2017 Oct 1;83(10):1074-1079.
3
Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.胃癌切除术后淋巴结清扫数量与生存情况:来自美国胃癌协作组的分析
J Am Coll Surg. 2015 Aug;221(2):291-9. doi: 10.1016/j.jamcollsurg.2015.04.024. Epub 2015 May 5.
4
Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.胃癌胃切除术后总淋巴结计数对分期及生存的影响:来自美国大型人群数据库的数据
J Clin Oncol. 2005 Oct 1;23(28):7114-24. doi: 10.1200/JCO.2005.14.621.
5
Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.胃腺癌中检查到的阴性淋巴结数量不足的预后。
Eur J Surg Oncol. 2014 Mar;40(3):358-65. doi: 10.1016/j.ejso.2013.08.027. Epub 2013 Sep 8.
6
Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?对于进展期胃癌行D2淋巴结清扫的全胃切除术中,是否有必要沿脾血管解剖清扫胃后淋巴结?
Eur J Surg Oncol. 2017 Dec;43(12):2357-2365. doi: 10.1016/j.ejso.2017.09.008. Epub 2017 Sep 19.
7
Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.胃癌患者胃左动脉旁淋巴结的生存预后及临床病理特征:对D2淋巴结清扫术的意义
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14365-73. eCollection 2015.
8
Survival benefit of "D2-plus" gastrectomy in gastric cancer patients with duodenal invasion.“D2-plus”胃切除术对十二指肠侵犯的胃癌患者的生存获益。
Gastric Cancer. 2018 Mar;21(2):296-302. doi: 10.1007/s10120-017-0733-6. Epub 2017 Jun 5.
9
The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.不同淋巴结分期系统对胃腺癌手术后淋巴结≤15枚患者的预后价值。
Acta Chir Belg. 2018 Feb;118(1):1-6. doi: 10.1080/00015458.2017.1346036. Epub 2017 Jul 3.
10
The prognostic value of lymph nodes count on survival of patients with node-negative gastric cancer.淋巴结计数对无淋巴结转移胃癌患者生存的预后价值。
Oncotarget. 2016 Jul 12;7(28):43680-43688. doi: 10.18632/oncotarget.9845.

引用本文的文献

1
Clinicopathological Factors Predisposing to No. 12a Lymph Node Metastasis in Gastric Cancer: A Prospective Cohort Analysis.胃癌第12a组淋巴结转移的临床病理相关因素:一项前瞻性队列分析
Cancer Rep (Hoboken). 2025 Jun;8(6):e70239. doi: 10.1002/cnr2.70239.
2
Construction of a modified TNM staging system and prediction model based on examined lymph node counts for gastric cancer patients at pathological stage N3.基于病理分期为N3的胃癌患者检查淋巴结计数构建改良TNM分期系统及预测模型。
Front Oncol. 2025 Apr 3;15:1569736. doi: 10.3389/fonc.2025.1569736. eCollection 2025.
3
The optimal number of lymph node dissections in three-field lymphadenectomy for esophageal squamous cell carcinoma: a large retrospective study.食管鳞状细胞癌三野淋巴结清扫术中淋巴结清扫的最佳数量:一项大型回顾性研究
Langenbecks Arch Surg. 2025 Apr 5;410(1):121. doi: 10.1007/s00423-025-03686-9.
4
Effect of Indocyanine Green-Guided Lymphadenectomy During Gastrectomy on Survival: Individual Patient Data Meta-Analysis.胃癌根治术中吲哚菁绿引导下淋巴结清扫对生存的影响:个体患者数据荟萃分析
Cancers (Basel). 2025 Mar 14;17(6):980. doi: 10.3390/cancers17060980.
5
D2 Lymphadenectomy for Gastric Cancer: Advancements and Technical Considerations.胃癌的D2淋巴结清扫术:进展与技术考量
Ann Surg Oncol. 2025 Mar;32(3):2129-2140. doi: 10.1245/s10434-024-16545-6. Epub 2024 Nov 26.
6
Effect of visceral obesity on outcomes of fluorescence-guided lymphadenectomy during laparoscopic gastrectomy for gastric cancer: analysis of a randomized phase 3 trial.内脏肥胖对胃癌腹腔镜胃切除术中荧光引导淋巴结清扫术结局的影响:一项随机3期试验的分析
Chin J Cancer Res. 2024 Oct 30;36(5):503-516. doi: 10.21147/j.issn.1000-9604.2024.05.04.
7
Finding the minimum number of retrieved lymph nodes and negative lymph nodes in gastric cancer surgery: a real-world study.在胃癌手术中找到最少的检出淋巴结和阴性淋巴结数量:一项真实世界研究。
Int J Surg. 2024 Sep 1;110(9):5574-5584. doi: 10.1097/JS9.0000000000001626.
8
Short-Term Outcomes Analysis Comparing Open, Laparoscopic, Laparoscopic-Assisted, and Robotic Distal Gastrectomy for Locally Advanced Gastric Cancer: A Randomized Trials Network Analysis.比较开放手术、腹腔镜手术、腹腔镜辅助手术和机器人辅助远端胃癌切除术治疗局部进展期胃癌的短期结果分析:一项随机试验网络分析
Cancers (Basel). 2024 Apr 23;16(9):1620. doi: 10.3390/cancers16091620.
9
Laparoscopic Versus Open Gastrectomy for Advanced Gastric Cancer: A Meta-Analysis of Randomized Controlled Trials.腹腔镜与开放胃切除术治疗进展期胃癌:一项随机对照试验的Meta分析
J Gastrointest Cancer. 2024 Jun;55(2):652-661. doi: 10.1007/s12029-024-01048-0. Epub 2024 Apr 2.
10
Distribution of Perigastric Station 4d Lymph Nodes in Vascularized Gastroepiploic Lymph Node Transfer: An Anatomic Study and Case Series.胃周站 4d 淋巴结在胃网膜血管化淋巴结转移中的分布:一项解剖学研究和病例系列。
Ann Surg Oncol. 2024 Jun;31(6):3694-3704. doi: 10.1245/s10434-024-15113-2. Epub 2024 Mar 26.

本文引用的文献

1
Harvest of at Least 23 Lymph Nodes is Indispensable for Stage N3 Gastric Cancer Patients.对于N3期胃癌患者,至少切除23个淋巴结是必不可少的。
Ann Surg Oncol. 2017 Apr;24(4):998-1002. doi: 10.1245/s10434-016-5667-4. Epub 2016 Nov 9.
2
Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System.残胃癌的分期:转移淋巴结比率与国际抗癌联盟第7版系统的比较
Ann Surg Oncol. 2016 Dec;23(13):4322-4331. doi: 10.1245/s10434-016-5390-1. Epub 2016 Jul 1.
3
Japanese gastric cancer treatment guidelines 2014 (ver. 4).《日本胃癌治疗指南2014(第4版)》
Gastric Cancer. 2017 Jan;20(1):1-19. doi: 10.1007/s10120-016-0622-4. Epub 2016 Jun 24.
4
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015.意大利胃癌研究小组(GIRCG)胃癌分期与治疗指南:2015年版
Gastric Cancer. 2017 Jan;20(1):20-30. doi: 10.1007/s10120-016-0615-3. Epub 2016 Jun 2.
5
A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems.基于解剖和数字系统的混合型胃癌淋巴结分期系统。
PLoS One. 2016 Mar 11;11(3):e0149555. doi: 10.1371/journal.pone.0149555. eCollection 2016.
6
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.腹腔镜与开腹 D2 远端胃癌根治术治疗进展期胃癌的疗效比较:一项随机对照临床试验。
J Clin Oncol. 2016 Apr 20;34(12):1350-7. doi: 10.1200/JCO.2015.63.7215. Epub 2016 Feb 22.
7
Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01).与开放性远端胃癌切除术相比,腹腔镜远端胃癌切除术治疗Ⅰ期胃癌的发病率降低:一项多中心随机对照试验(KLASS-01)的短期结果
Ann Surg. 2016 Jan;263(1):28-35. doi: 10.1097/SLA.0000000000001346.
8
Extent of lymph node dissection for adenocarcinoma of the stomach.胃癌腺癌的淋巴结清扫范围。
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD001964. doi: 10.1002/14651858.CD001964.pub4.
9
A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901).一项多机构前瞻性II期可行性研究:腹腔镜辅助远端胃癌D2淋巴结清扫术治疗局部进展期胃癌(JLSSG0901)
World J Surg. 2015 Nov;39(11):2734-41. doi: 10.1007/s00268-015-3160-z.
10
Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial.腹腔镜D2淋巴结清扫术式全胃切除术治疗局部进展期胃癌的疗效:KLASS-02多中心随机对照临床试验方案
BMC Cancer. 2015 May 5;15:355. doi: 10.1186/s12885-015-1365-z.

清扫29枚淋巴结达最佳状态的淋巴结切除术与晚期胃癌患者生存率提高相关:一项纳入25000例患者的国际数据库研究

Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.

作者信息

Woo Yanghee, Goldner Bryan, Ituarte Philip, Lee Byrne, Melstrom Laleh, Son Taeil, Noh Sung Hoon, Fong Yuman, Hyung Woo Jin

机构信息

Department of Surgery, City of Hope National Medical Center, Duarte, CA.

Department of Surgery, City of Hope National Medical Center, Duarte, CA; Department of Surgery, Kaiser Permanente, Los Angeles, CA.

出版信息

J Am Coll Surg. 2017 Apr;224(4):546-555. doi: 10.1016/j.jamcollsurg.2016.12.015. Epub 2016 Dec 23.

DOI:10.1016/j.jamcollsurg.2016.12.015
PMID:28017807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5606192/
Abstract

BACKGROUND

Gastric adenocarcinoma is an aggressive disease with frequent lymph node (LN) metastases for which lymphadenectomy results in a survival benefit. In the US, the National Comprehensive Cancer Network guidelines recommend D2 lymphadenectomy or a minimum of 15 LNs retrieved. However, retrieval of only 15 LNs is considered by most international guidelines as inadequate. We sought to evaluate the survival benefits associated with a more complete lymphadenectomy.

STUDY DESIGN

An international database was constructed by combining gastric cancer cases from the Surveillance, Epidemiology, and End Results program database (n = 13,932) and the Yonsei University Gastric Cancer database (n = 11,358) (total n = 25,289). Kaplan-Meier survival analysis was performed along with Joinpoint analysis to obtain the optimal number of LNs to retrieve based on survival. Prognostic significance of number of nodes retrieved was then confirmed with univariate and multivariate analyses.

RESULTS

Analysis for both mean and median survival yielded 29 LNs removed as the Joinpoint. This was confirmed with multivariate analysis, where 15 retrieved LNs cutoff fell out of the model and 29 retrieved LNs remained intact, with a hazard ratio of 0.799 (95% CI 0.759 to 0.842; p < 0.001). Stage-stratified Kaplan-Meier analysis for a cutoff point of 29 LNs also demonstrated a statistically significant improvement in survival.

CONCLUSIONS

Joinpoint analysis has allowed for the creation of a model demonstrating the point at which additional dissection would not provide additional benefit. This large international dataset analysis demonstrates that the maximal survival advantage is seen by performing a lymphadenectomy with a minimum of 29 LNs retrieved.

摘要

背景

胃腺癌是一种侵袭性疾病,常发生淋巴结转移,淋巴结清扫术可带来生存获益。在美国,国家综合癌症网络指南推荐行D2淋巴结清扫术或至少切除15枚淋巴结。然而,大多数国际指南认为仅切除15枚淋巴结是不够的。我们试图评估更彻底的淋巴结清扫术带来的生存获益。

研究设计

通过合并监测、流行病学和最终结果计划数据库(n = 13932)和延世大学胃癌数据库(n = 11358)中的胃癌病例构建了一个国际数据库(总计n = 25289)。进行了Kaplan-Meier生存分析和Joinpoint分析,以根据生存情况获得最佳的淋巴结切除数量。然后通过单因素和多因素分析确认切除淋巴结数量的预后意义。

结果

均值和中位数生存分析均得出切除29枚淋巴结为Joinpoint。多因素分析证实了这一点,其中切除15枚淋巴结的临界值被排除在模型之外,而切除29枚淋巴结的临界值保持不变,风险比为0.799(95%CI 0.759至0.842;p < 0.001)。以29枚淋巴结为临界值的分期分层Kaplan-Meier分析也显示出生存率有统计学意义的改善。

结论

Joinpoint分析创建了一个模型,表明进一步的解剖不会带来额外益处的临界点。这项大型国际数据集分析表明,切除至少29枚淋巴结的淋巴结清扫术可获得最大的生存优势。